Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Why breast cancer survivors don't take their medicine, and what can be done about it.

2.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

3.

Never in a million years did I think I'd have to limit my chemotherapy.

4.

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

5.

Recently released national data on drug use and abuse among Americans.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot